{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-192381","form_type":"8-K","ticker":"SONM","cik":"0001178697","company_name":"DNA X, Inc.","filed_at":"2022-07-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.141943+00:00","generated_at":"2026-06-24T15:41:19.275941+00:00","sec_items":["1.01","3.02","5.01","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Sonim completes $12.5M first closing of equity investment from AJP; control changes hands","bullets":["First closing of $12.5M equity investment by AJP Holding at $0.84/share; AJP now owns ~40.7% of Sonim.","Second closing for $5M expected ~Aug 1; combined AJP and CEO Peter Liu will own ~52%.","Board reconstituted: new directors Wang, Steenstra, Cassano; Kneuer and Swenson resigned.","CFO Robert Tirva resigned; Clay Crolius appointed CFO with base salary $275K.","Press release: $15.9M in carrier orders; expansion into semi-rugged and 5G markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-192381","json":"https://secwatch.observer/filing/0001193125-22-192381.json","markdown":"https://secwatch.observer/filing/0001193125-22-192381.md","text":"https://secwatch.observer/filing/0001193125-22-192381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/d305491d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T15:41:19.275941+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ab3d6623c","claim":"Robert Tirva resigned as President, Chief Financial Officer and Chief Operating Officer at DNA X, Inc..","evidence_excerpt":"On July 13, 2022, Robert Tirva, President, Chief Financial Officer and Chief Operating Officer (principal financial and accounting officer) of the Company resigned from his positions with the Company and its affiliates.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President, Chief Financial Officer and Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"23f03f0ade","claim":"Clay Crolius was appointed as Chief Financial Officer at DNA X, Inc..","evidence_excerpt":"the Board appointed Clay Crolius as Chief Financial Officer (principal financial and accounting officer) of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a777df3599","claim":"John Kneuer resigned as Director at DNA X, Inc..","evidence_excerpt":"John Kneuer and Sue Swenson resigned from the Board and each respective committee of the Board to which they were appointed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ad9140dfd1","claim":"Jeffrey Wang was appointed as Director, Chairman of the Board at DNA X, Inc..","evidence_excerpt":"Jeffrey Wang, Director, Chairman of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director, Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"b1869f1d8a","claim":"Sue Swenson resigned as Director at DNA X, Inc..","evidence_excerpt":"John Kneuer and Sue Swenson resigned from the Board and each respective committee of the Board to which they were appointed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}